Literature DB >> 7805578

Functional maturation of creatine kinase in rat brain.

D Holtzman1, M Tsuji, T Wallimann, W Hemmer.   

Abstract

The physiological role of the phosphocreatine (PCr)/creatine kinase (CK) system has been studied in rat brain by comparing maturational changes in in vivo CK-catalyzed reaction rate and activities of CK isoenzymes. The CK-catalyzed reaction rates, measured by 31P-nuclear magnetic resonance spectroscopy, increased 4-fold between 12 and 17 days of age. The mitochondrial CK (Mi-CK) isoenzyme, as a percentage of total CK, increased to the same extent over this relatively narrow age period. Cytosolic CK (B-CK) was active earlier and, with the total CK activity, increased steadily over a longer time course. An immunohistochemical study of cerebellum showed Mi-CK predominantly in gray matter, while the cytosolic CK was present in rather large concentrations in both gray and white matter. In the molecular layer, B-CK was most prominent in the Bergmann glial cells, while Mi-CK was more prominent in Purkinje neurons. During development a redistribution of Mi-CK from the Purkinje cell bodies to their processes was observed. These results point to regional differences in CK content and in isoenzyme-specific localizations. The increase in CK activity is temporally coincident with the maturational appearance of closely coupled decreases in brain PCr and ATP during hypoxia. These maturational changes suggest that the activity of the PCr/CK system, particularly the Mi-CK isoenzyme, is central in regulation of brain ATP.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7805578     DOI: 10.1159/000111343

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  8 in total

1.  Anoxic ATP depletion in neonatal mice brainstem is prevented by creatine supplementation.

Authors:  B Wilken; J M Ramirez; I Probst; D W Richter; F Hanefeld
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-05       Impact factor: 5.747

2.  Mitochondrial creatine kinase functional development in post-natal rat skeletal muscle. A combined polarographic/31P NMR study.

Authors:  F Kernec; L Nadal; C Rocher; P Mateo; J de Certaines; E Le Rumeur
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

3.  Gray matter-specific changes in brain bioenergetics after acute sleep deprivation: a 31P magnetic resonance spectroscopy study at 4 Tesla.

Authors:  David T Plante; George H Trksak; J Eric Jensen; David M Penetar; Caitlin Ravichandran; Brady A Riedner; Wendy L Tartarini; Cynthia M Dorsey; Perry F Renshaw; Scott E Lukas; David G Harper
Journal:  Sleep       Date:  2014-12-01       Impact factor: 5.849

Review 4.  Creatine kinase in non-muscle tissues and cells.

Authors:  T Wallimann; W Hemmer
Journal:  Mol Cell Biochem       Date:  1994 Apr-May       Impact factor: 3.396

5.  Changes in dihydrolipoamide dehydrogenase expression and activity during postnatal development and aging in the rat brain.

Authors:  Liang-Jun Yan; Nopporn Thangthaeng; Michael J Forster
Journal:  Mech Ageing Dev       Date:  2008-02-06       Impact factor: 5.432

6.  The creatine kinase/creatine connection to Alzheimer's disease: CK-inactivation, APP-CK complexes and focal creatine deposits.

Authors:  Tanja S Bürklen; Uwe Schlattner; Ramin Homayouni; Kathleen Gough; Margaret Rak; Adriana Szeghalmi; Theo Wallimann
Journal:  J Biomed Biotechnol       Date:  2006

Review 7.  Creatine Metabolism in Female Reproduction, Pregnancy and Newborn Health.

Authors:  Anna Maria Muccini; Nhi T Tran; Deborah L de Guingand; Mamatha Philip; Paul A Della Gatta; Robert Galinsky; Larry S Sherman; Meredith A Kelleher; Kirsten R Palmer; Mary J Berry; David W Walker; Rod J Snow; Stacey J Ellery
Journal:  Nutrients       Date:  2021-02-02       Impact factor: 5.717

8.  Developmental changes in the expression of creatine synthesizing enzymes and creatine transporter in a precocial rodent, the spiny mouse.

Authors:  Zoe Ireland; Aaron P Russell; Theo Wallimann; David W Walker; Rod Snow
Journal:  BMC Dev Biol       Date:  2009-07-01       Impact factor: 1.978

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.